A C McDonald Selected Research

7- ((9- fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino- 4- methylcoumarin

6/2014

Galnon, a galanin receptor agonist, improves intrinsic cortical bone tissue properties but exacerbates bone loss in an ovariectomised rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A C McDonald Research Topics

Disease

3	Adenocarcinoma 01/2018 - 10/2001
3	Rectal Neoplasms (Rectal Cancer) 10/2012 - 01/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2018
2	Margins of Excision 10/2012 - 01/2006
1	Dermatitis 12/2014
1	Inflammation (Inflammations) 12/2014
1	Bone Resorption 06/2014
1	Neoplasm Metastasis (Metastasis) 08/2008
1	Bone Fractures (Bone Fracture) 04/2007
1	Carcinoma (Carcinomatosis) 03/2006
1	Pain (Aches) 01/2006
1	Stomach Neoplasms (Stomach Cancer) 09/2002
1	Hypersensitivity (Allergy) 10/2001
1	Pulmonary Embolism 10/2001
1	Enteritis 10/2001
1	Sepsis (Septicemia) 10/2001
1	Gastroenteritis 05/2001
1	Myocardial Infarction 05/2000

Drug/Important Bio-Agent (IBA)

2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2018
2	Gemcitabine FDA Link 01/2018 - 01/2018
2	Leucovorin (Folinic Acid)FDA Link 01/2018 - 01/2018
2	Capecitabine (Xeloda)FDA Link 01/2006 - 09/2002
2	Cisplatin (Platino)FDA LinkGeneric 09/2002 - 10/2001
2	Epirubicin (Ellence)FDA LinkGeneric 09/2002 - 10/2001
1	pyrimidineIBA 01/2018
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	DCMP Deaminase (Deoxycytidylate Deaminase)IBA 01/2018
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	sharpinIBA 12/2014
1	7- ((9- fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino- 4- methylcoumarinIBA 06/2014
1	GalaninIBA 04/2007
1	AlbuminsIBA 03/2006
1	C-Reactive ProteinIBA 03/2006
1	XELOXIBA 01/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2006
1	Pharmaceutical PreparationsIBA 10/2001
1	raltitrexed (D 1694)IBA 10/2001
1	Drinking WaterIBA 05/2001

Therapy/Procedure

3	Radiotherapy 08/2008 - 01/2006
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2001
2	Therapeutics 08/2008 - 05/2000
1	Adjuvant Chemotherapy 01/2018
1	Neoadjuvant Therapy 10/2012
1	Intravenous Infusions 01/2006
1	Combination Drug Therapy (Combination Chemotherapy) 10/2001